Figure 6

Treatment relevance of pyroptosis. Half maximal inhibitory concentration (IC50) of cisplatin (a), rapamycin (b), gemcitabine (c), paclitaxel (d), docetaxel (e), and methotrexate (f) grouped by low- or high-PPI in partial genitourinary tract cancers. (g) Correlation between PPI and drug sensitivity from CellMiner database. (h) Association between PPI and treatment pathway scores in pan-cancer. Colours indicated the correlation coefficients and shapes demonstrated the significance of the correlation.